Intrinsiqq
Grail, Inc. logo

Grail, Inc. (GRAL) Insider Trading

Last 12 months

Insiders sold $38.1M and bought nothing on the open market.

27% of the selling was scheduled in advance under 10b5-1 plans. Chief Executive Officer Robert P Ragusa sold $6.17M on Apr 8, 19% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market
−$38.1M
0 buys · 21 sales
Under a 10b5-1 plan
27%
of the value sold
Insiders who bought / sold
0 / 4
executives and directors
Last open-market buy
None
in the last two years

Get an email when GRAL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 1510b5-1 plan
    Joshua J. Ofman
    Chief Executive Officer · sold 20,000 at avg $136.85
    $2.74M
    5.5% of stake
  • Oct 5No plan
    Andrew John Partridge
    Chief Growth Officer · sold 7,873 at $146.39
    $1.15M
    4.8% of stake
  • Oct 5No plan
    Aaron Freidin
    Chief Financial Officer · sold 23,619 at $146.39
    $3.46M
    9.5% of stake
  • Sep 2110b5-1 plan
    Aaron Freidin
    Chief Financial Officer · sold 4,100 at avg $93.34
    $383k
    1.6% of stake
  • Sep 2110b5-1 plan
    Joshua J. Ofman
    Chief Executive Officer · sold 61,452 at avg $97.74
    $6.01M
    15% of stake
  • Aug 2710b5-1 plan
    Joshua J. Ofman
    Chief Executive Officer · sold 5,000 at $85.02
    $425k
    1.2% of stake
  • Aug 2710b5-1 plan
    Aaron Freidin
    Chief Financial Officer · sold 7,900 at $85.01
    $672k
    3.0% of stake
  • Jun 4No plan
    Andrew John Partridge
    Chief Growth Officer · sold 1,491 at $61.08
    $91k
    0.9% of stake
  • Apr 8No plan
    Aaron Freidin
    Chief Financial Officer · sold 45,806 at $49.92
    $2.29M
    15% of stake
  • Apr 8No plan
    Robert P Ragusa
    Chief Executive Officer · sold 123,502 at $49.92
    $6.17M
    19% of stake
  • Apr 8No plan
    Joshua J. Ofman
    President · sold 61,665 at $49.92
    $3.08M
    14% of stake
  • Mar 5 – 9No plan
    Aaron Freidin
    Chief Financial Officer · sold 3,147 at avg $48.96
    $154k
    1.0% of stake
  • Mar 5 – 9No plan
    Joshua J. Ofman
    President · sold 3,627 at avg $48.86
    $177k
    0.8% of stake
  • Mar 5 – 9No plan
    Robert P Ragusa
    Chief Executive Officer · sold 8,441 at avg $48.48
    $409k
    1.3% of stake
  • Mar 2No plan
    Joshua J. Ofman
    President · sold 17,002 at avg $50.17
    $853k
    3.7% of stake
  • Mar 2No plan
    Aaron Freidin
    Chief Financial Officer · sold 9,573 at avg $50.17
    $480k
    3.0% of stake
  • Mar 2No plan
    Robert P Ragusa
    Chief Executive Officer · sold 37,504 at avg $50.17
    $1.88M
    5.5% of stake
  • Dec 3, 2025No plan
    Joshua J. Ofman
    President · sold 13,000 at $100.00
    $1.3M
    3.4% of stake
  • Dec 3, 2025No plan
    Robert P Ragusa
    Chief Executive Officer · sold 40,000 at avg $95.24
    $3.81M
    5.5% of stake
  • Dec 3, 2025No plan
    Aaron Freidin
    Chief Financial Officer · sold 25,000 at $99.15
    $2.48M
    8.8% of stake
  • Nov 17, 2025No plan
    Aaron Freidin
    Chief Financial Officer · sold 1,697 at $79.20
    $134k
    0.6% of stake
  • Nov 17, 2025No plan
    Illumina, Inc.
    Large holder · sold 1,000,000 at $79.85
    $79.8M
    22% of stake
  • Oct 15, 2025 – Oct 16, 202510b5-1 plan
    Joshua J. Ofman
    President · sold 14,979 at avg $78.47
    $1.18M
    3.8% of stake
  • Oct 15, 2025No plan
    Robert P Ragusa
    Chief Executive Officer · sold 7,239 at $68.88
    $499k
    1.0% of stake
  • Oct 6, 2025No plan
    Joshua J. Ofman
    President · sold 81,385 at $62.50
    $5.09M
    17% of stake
  • Oct 2, 202510b5-1 plan
    Joshua J. Ofman
    President · sold 9,692 at $64.00
    $620k
    2.0% of stake
  • Aug 19, 2025No plan
    Joshua J. Ofman
    President · sold 4,202 at $32.02
    $135k
    0.9% of stake
  • Aug 19, 2025No plan
    Aaron Freidin
    Chief Financial Officer · sold 877 at $32.02
    $28k
    0.3% of stake
  • Jul 15, 202510b5-1 plan
    Aaron Freidin
    Chief Financial Officer · sold 8,000 at $38.93
    $311k
    2.7% of stake
  • Jul 1, 2025No plan
    Chun R Ding
    Large holder · sold 339,800 at avg $49.53
    $16.8M
    9.3% of stake
  • Jun 30, 202510b5-1 plan
    Joshua J. Ofman
    President · sold 9,692 at $52.00
    $504k
    1.9% of stake
  • Jun 12, 202510b5-1 plan
    Joshua J. Ofman
    President · sold 9,692 at $42.30
    $410k
    1.9% of stake
  • May 2, 2025No plan
    Joshua J. Ofman
    President · sold 48,213 at $33.93
    $1.64M
    8.6% of stake
  • May 2, 2025No plan
    Aaron Freidin
    Chief Financial Officer · sold 41,150 at $33.93
    $1.4M
    12% of stake
  • May 2, 2025No plan
    Robert P Ragusa
    Chief Executive Officer · sold 94,035 at $33.93
    $3.19M
    11% of stake
  • Mar 11, 2025No plan
    Aaron Freidin
    Chief Financial Officer · sold 1,816 at $31.20
    $57k
    0.5% of stake
  • Mar 11, 2025No plan
    Robert P Ragusa
    Chief Executive Officer · sold 7,625 at $31.21
    $238k
    0.9% of stake
  • Mar 11, 2025No plan
    Joshua J. Ofman
    President · sold 2,109 at $31.20
    $66k
    0.4% of stake
  • Mar 7, 2025No plan
    Robert P Ragusa
    Chief Executive Officer · sold 7,625 at $31.21
    $238k
    0.9% of stake
  • Mar 7, 2025No plan
    Joshua J. Ofman
    President · sold 2,109 at $31.20
    $66k
    0.4% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GRAL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

Spot a number that looks wrong? Check it in GRAL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GRAL

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.